The stock of Creative Medical Technology Holdings Inc (CELZ) has seen a -26.42% decrease in the past week, with a -55.28% drop in the past month, and a 10.00% flourish in the past quarter. The volatility ratio for the week is 16.54%, and the volatility levels for the past 30 days are at 18.10% for CELZ. The simple moving average for the past 20 days is -43.98% for CELZ’s stock, with a -34.65% simple moving average for the past 200 days.
Is It Worth Investing in Creative Medical Technology Holdings Inc (NASDAQ: CELZ) Right Now?
The stock has a 36-month beta value of 4.55. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CELZ is 2.48M, and at present, short sellers hold a 7.46% of that float. On March 26, 2025, the average trading volume of CELZ was 105.89K shares.
CELZ) stock’s latest price update
Creative Medical Technology Holdings Inc (NASDAQ: CELZ)’s stock price has gone decline by -16.67 in comparison to its previous close of 2.64, however, the company has experienced a -26.42% decrease in its stock price over the last five trading days. zacks.com reported 2025-03-25 that Creative Medical Technology Holdings, Inc. (CELZ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
CELZ Trading at -40.88% from the 50-Day Moving Average
After a stumble in the market that brought CELZ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.12% of loss for the given period.
Volatility was left at 18.10%, however, over the last 30 days, the volatility rate increased by 16.54%, as shares sank -51.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.38% upper at present.
During the last 5 trading sessions, CELZ fell by -26.42%, which changed the moving average for the period of 200-days by -49.07% in comparison to the 20-day moving average, which settled at $3.93. In addition, Creative Medical Technology Holdings Inc saw -4.76% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CELZ starting from Finger Michael H., who sale 750 shares at the price of $5.75 back on Feb 19 ’25. After this action, Finger Michael H. now owns 351 shares of Creative Medical Technology Holdings Inc, valued at $4,312 using the latest closing price.
Finger Michael H., the Director of Creative Medical Technology Holdings Inc, sale 750 shares at $5.00 during a trade that took place back on Feb 18 ’25, which means that Finger Michael H. is holding 1,101 shares at $3,750 based on the most recent closing price.
Stock Fundamentals for CELZ
Current profitability levels for the company are sitting at:
- -522.17 for the present operating margin
- -4.72 for the gross margin
The net margin for Creative Medical Technology Holdings Inc stands at -499.41. The total capital return value is set at -0.91. Equity return is now at value -65.85, with -63.20 for asset returns.
Currently, EBITDA for the company is -5.63 million with net debt to EBITDA at 1.07. When we switch over and look at the enterprise to sales, we see a ratio of -32.86. The liquidity ratio also appears to be rather interesting for investors as it stands at 18.73.
Conclusion
To sum up, Creative Medical Technology Holdings Inc (CELZ) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
